Mode
Text Size
Log in / Sign up
N/A N=5,047 Randomized Treatment

Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD

Clinical Decision Support · Buprenorphine · Opioid-use Disorder

Enrolled (actual)
5,047
Serious AEs
0.0%
Results posted
Jun 2022
Primary outcome: Primary: Count of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual Care — 347; 271 Participants — p=0.58

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Clinical Decision Support (CDS) (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Yale University
Primary completion
May 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Count of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual Care
347; 271 0.58
SECONDARY
Count of Those With Referral to Follow-up for Ongoing MOUD Treatment (Patient Level)
367; 226 0.95
SECONDARY
Rates Receiving a MAT Appointment Who go to the Appointment
SECONDARY
Number of Clinicians Providing ED-initiated BUP
151; 88 0.01 sig
SECONDARY
Number of Clinicians Providing Referral of Any Ongoing MOUD Treatment
141; 100 0.48
SECONDARY
Number of Clinicians Who Have Received Drug Addiction Treatment Act (DATA) of 2000 Training
50; 30 0.27

Summary

Emergency Departments (EDs) frequently care for individuals with Opioid Use Disorder (OUD). Buprenorphine (BUP) is an effective treatment option for patients with OUD that can safely be initiated in the ED. At present, BUP is rarely initiated as a part of routine ED care. Clinical decision support (CDS) represents a potential approach to accelerate adoption of this best practice into routine emergency care. The goal of this trial is to determine whether implementation of a user-centered clinical decision support (CDS) system can increase adoption of initiation of BUP into the routine emergency care of individuals with OUD.

Eligibility Criteria

Inclusion Criteria

Clinicians

  • All clinicians working in Emergency Departments in the selected sites

Patients

  • 18 years or older
  • Will meet an EHR-derived phenotype suggesting possible OUD will be included in the analysis
  • Will be discharged from the ED
  • Not pregnant
  • Not currently taking any medication for Opioid Use Disorder

Exclusion Criteria

Patients

  • Have a medical or psychiatric condition that requires hospitalization during the ED visit
  • Have prior enrollment in the current study
  • Currently in addiction treatment
  • Be a prisoner or in police custody at the time of ED visit

Note: The CDS will also be available for physicians to use when patients do not meet the EHR phenotype. These patients will be excluded from the primary analyses

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03658642). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search